4/A: SeaStar Medical CFO Corrects Stock Unit Reporting in Amended SEC Filing

SeaStar Medical's CFO, David A. Green, files an amended SEC Form 4 to correct the number of restricted stock units (RSUs) granted, attributing the error to an administrative oversight.

Summary

• David A. Green, CFO of SeaStar Medical Holding Corporation, filed an amended Form 4 with the SEC.
• The amendment corrects an error in the original filing regarding the number of restricted stock units (RSUs) granted to Green.
• The original report, filed on April 16, 2024, overstated the number of RSUs.
• The corrected number of RSUs granted on April 12, 2024, is 18,000 (450,000 pre-reverse split), down from the previously reported 30,100 RSUs (752,500 pre-reverse split).
• The RSUs will vest over time, with 25% vesting after one year from January 10, 2024, and the remaining 75% vesting monthly over the following 36 months from January 10, 2025.
• The company effectuated a 1-for-25 reverse stock split on June 7, 2024.

Sentiment

Score: 6

Explanation: The document is a routine correction of an administrative error in an SEC filing. It doesn't indicate any significant positive or negative developments for the company.

Negatives

• The original SEC filing contained an error, requiring an amendment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. The correction of the RSU numbers ensures transparency and compliance with SEC regulations.

Stakeholder Impact

• Shareholders benefit from accurate reporting of executive compensation.

Key Dates

Keywords

SEC Filing, Form 4, Amendment, Restricted Stock Units, RSUs, SeaStar Medical, ICU, David A. Green, CFO, Reverse Stock Split, Vesting